Stock Worth Mentioning Today: Is Lantheus Holdings Inc’s Fuel For Real? The Stock Just Increased Again

Stock Worth Mentioning Today: Is Lantheus Holdings Inc's Fuel For Real? The Stock Just Increased Again

The stock of Lantheus Holdings Inc (NASDAQ:LNTH) is a huge mover today! About 668,252 shares traded hands or 15.55% up from the average. Lantheus Holdings Inc (NASDAQ:LNTH) has risen 394.59% since April 20, 2016 and is uptrending. It has outperformed by 390.04% the S&P500.
The move comes after 5 months positive chart setup for the $339.66 million company. It was reported on Nov, 22 by Barchart.com. We have $10.17 PT which if reached, will make NASDAQ:LNTH worth $23.78 million more.

Lantheus Holdings Inc (NASDAQ:LNTH) Ratings Coverage

Out of 5 analysts covering Lantheus Holdings (NASDAQ:LNTH), 2 rate it a “Buy”, 0 “Sell”, while 3 “Hold”. This means 40% are positive. Lantheus Holdings has been the topic of 9 analyst reports since August 31, 2015 according to StockzIntelligence Inc. The company was maintained on Monday, August 29 by Jefferies. The firm earned “Neutral” rating on Monday, August 31 by Robert W. Baird. Wells Fargo downgraded the shares of LNTH in a report on Wednesday, September 30 to “Market Perform” rating. The stock of Lantheus Holdings Inc (NASDAQ:LNTH) earned “Neutral” rating by Credit Suisse on Friday, December 11. The stock of Lantheus Holdings Inc (NASDAQ:LNTH) earned “Outperform” rating by RBC Capital Markets on Wednesday, February 24. The firm has “Neutral” rating given on Friday, September 23 by Credit Suisse.

According to Zacks Investment Research, “Lantheus Holdings, Inc. is involved in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products for diagnosis of cardiovascular and other diseases. It serves to hospitals, clinics, group practices, integrated delivery networks, group purchasing organizations, radiopharmacies and wholesalers. Lantheus Holdings, Inc. is based in NORTH BILLERICA, United States.”

More notable recent Lantheus Holdings Inc (NASDAQ:LNTH) news were published by: Fool.com which released: “Why Shares of Flexion Therapeutics, Inc., Lantheus Holdings Inc, and PDL …” on November 16, 2016, also Businesswire.com with their article: “Lantheus Holdings, Inc. Announces Upsize of Public Offering to 3500000 Shares …” published on November 16, 2016, Fool.com published: “Why Lantheus Holdings Inc. Sold Lower Friday” on September 09, 2016. More interesting news about Lantheus Holdings Inc (NASDAQ:LNTH) were released by: Businesswire.com and their article: “Lantheus Holdings, Inc. Reports 2016 Second Quarter Financial Results” published on August 04, 2016 as well as Businesswire.com‘s news article titled: “Lantheus Holdings, Inc. Announces Public Offering of 5200000 Shares of Common …” with publication date: September 08, 2016.

LNTH Company Profile

Lantheus Holdings, Inc., incorporated on November 30, 2007, develops, makes and commercializes diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. The Company’s portfolio of approximately 10 commercial products is spread across a range of imaging modalities. The Company’s contrast agents are typically non-radioactive compounds that are used in diagnostic procedures, such as cardiac ultrasounds, or echocardiograms, x-ray imaging or magnetic resonance imaging (MRI), which are used by physicians to progress the clarity of the diagnostic image. Radiopharmaceuticals are radioactive pharmaceuticals used by clinicians to perform nuclear imaging procedures. The Company’s imaging agents include contrast agents and medical radiopharmaceuticals (including technetium generators), including DEFINITY, TechneLite, Xenon Xe 133 Gas (Xenon), Cardiolite and Neurolite.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Comment